Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Reinvestment Rate
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Reinvestment Rate of 5.76x as of December 2025, reinvesting ₩3.06 Billion (capex ₩2.23 Billion plus investments ₩831.46 Million) from operating cash flow of ₩532.03 Million. See cash generation quality of Jeil Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jeil Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Jeil Pharmaceutical Co Ltd across 4 annual periods. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Jeil Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Jeil Pharmaceutical Co Ltd. See 271980 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.47x | ₩7.93 Billion | ₩3.21 Billion | ₩6.61 Billion | ▲ +661.2% |
| 2021 | 0.32x | ₩6.19 Billion | ₩19.10 Billion | ₩5.34 Billion | ▲ +638.5% |
| 2019 | 0.04x | ₩1.27 Billion | ₩28.96 Billion | ₩1.09 Billion | ▼ -95.5% |
| 2018 | 0.96x | ₩20.69 Billion | ₩21.45 Billion | ₩10.29 Billion | — |